聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 58 分钟 38 秒 前

Alphatec Spine Announces Executive Leadership Changes

周四, 01/02/2014 - 20:23
Mike Plunkett Promoted to Chief Operating Officer CARLSBAD, Calif., Jan. 2, 2014 -- (Healthcare Sales & Marketing Network) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physi...
Devices, Orthopaedic, Neurosurgery, Personnel
Alphatec Spine, spine surgery, pedicle screw

Marina Biotech and Mirna Therapeutics Amend License Agreement for the Development of microRNA-Based Therapeutics

周四, 01/02/2014 - 17:21
Mirna Broadens Rights to Its Lead Cancer Therapeutic Candidate MRX34 BOSTON, MA and AUSTIN, TX--(Healthcare Sales & Marketing Network) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, and...
Biopharmaceuticals, Oncology, Licensing
Marina Biotech, Mirna Therapeutics, microRNA, SMARTICLES

Kinsa Receives First-Ever FDA Approval for Smartphone-Connected Oral Thermometer

周四, 01/02/2014 - 16:32
New Type of Thermometer Does Much More Than Just Take a Temperature, Tracks Spread of Flu NEW YORK, NY--(Healthcare Sales & Marketing Network) - Kinsa, a mission-driven, venture-backed startup, today announced 510(k) clearance for its smartphone-connect...
Devices, FDA
Kinsa Inc, Smart Thermometer, Oral Thermometer

SpineGuard Names Pierre Guyot to Board of Directors

周四, 01/02/2014 - 15:54
PARIS & SAN FRANCISCO--(Healthcare Sales & Marketing Network)--SpineGuard (FR0011464452 – ALSGD), an innovative medical device company focused on improving spine surgery safety, announced today that Pierre Guyot has been appointed to its Board of Directors...
Devices, Orthopaedic, Neurosurgery, Personnel
SpineGuard, PediGuard, pedicle screw, spine surgery

AtriCure Completes Acquisition of Estech

周四, 01/02/2014 - 15:51
WEST CHESTER, Ohio--(Healthcare Sales & Marketing Network)--AtriCure, Inc. (Nasdaq: ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/b/a ...
Devices, Cardiology, Mergers & Acquisitions
AtriCure, Estech, Endoscopic Technologies, atrial fibrillation, ablation

Smiths Medical Receives FDA 510(k) Clearance on Innovative Solution for Pain Management with CADD(R)-Solis Infusion Pump

周四, 01/02/2014 - 15:45
CADD®-Solis system combines PCA and Programmed Intermittent Bolus (PIB) deliveries for labor analgesia and post-operative pain management ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--Smiths Medical, a leading global medical device manufa...
Devices, Drug Delivery, FDA
Smiths Medical, CADD-Solis, Infusion Pump, Pain Management

MELA Sciences Appoints Healthcare Executive Jeff O’Donnell as Director and Streamlines Board to Support Refocused Go-to-Market Strategy

周四, 01/02/2014 - 15:40
Richard Steinhart Resigns as CFO IRVINGTON, N.Y.--(Healthcare Sales & Marketing Network)--MELA Sciences, Inc. (NASDAQ: MELA), developer of MelaFind®, an FDA approved optical diagnostic device that assists dermatologists in the diagnosis of melanoma,...
Devices, Diagnostics, Dermatology, Personnel
MELA Sciences, MelaFind, optical diagnostic, melanoma

Eisai Announces U.S. Availability of FYCOMPA(TM) (perampanel) CIII an Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy Age 12 and Older

周四, 01/02/2014 - 15:32
FYCOMPA is the First and Only FDA-Approved Non-Competitive AMPA Glutamate Receptor Antagonist Woodcliff Lake, NJ, January 2, 2014 / PRNewswire / — Eisai Inc. announced today that FYCOMPA™ (perampanel) CIII will be available to eligible patients by pres...
Biopharmaceuticals, Neurology, Product Launch
Eisai, FYCOMPA, perampanel, Epilepsy

NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing

周四, 01/02/2014 - 14:58
Dave Pfeiffer Named Alexar Chief Executive Officer MALVERN, Pa.--(Healthcare Sales & Marketing Network)--NeXeption, LLC, a biopharmaceutical management company that brings together product opportunities, management expertise and funding to reach compell...
Biopharmaceuticals, Venture Capital, Personnel
NeXeption, Alexar Therapeutics, Liver X receptor, A-110

Elekta Wins Public Tender to Deliver Cancer Care Solutions to China

周四, 01/02/2014 - 14:30
Health Department to expand its capacity to treat cancer with 15 linear accelerators from Elekta STOCKHOLM--(Healthcare Sales & Marketing Network)--To help manage the growing incidence of cancer, China’s Health Department of the People’s Liberation Army...
Devices, Oncology
Elekta, linear accelerator, Axesse, MOSAIQ, radiotherapy

Mazor Robotics Announces Two Renaissance Systems orders in the U.S. and International Markets

周四, 01/02/2014 - 13:26
Seven New Renaissance Systems Ordered in the 2013 Fourth Quarter; Enters 2014 with Install Base of 63 Systems CAESAREA, Israel--(Healthcare Sales & Marketing Network)--Mazor Robotics Ltd. (TASE: MZOR; NASDAQCM: MZOR), the developer of Renaissance™, an i...
Devices, Surgery
Mazor Robotics, Renaissance, robotic surgery

Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat

周四, 01/02/2014 - 13:13
SEATTLE, Jan. 2, 2014 -- (Healthcare Sales & Marketing Network) -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the partial clinical hold on to...
Biopharmaceuticals, Oncology, FDA
Cell Therapeutics, tosedostat, acute myeloid leukemia, myelodysplastic syndromes

Skyline Medical's STREAMWAY(R) System Provides New Option for Radiology

周四, 01/02/2014 - 13:03
Surgical Fluid Waste Disposal System Well Received at Radiological Society of North America Meeting MINNEAPOLIS, Jan. 2, 2014 -- (Healthcare Sales & Marketing Network) -- Skyline Medical Inc. (OTCQB: SKLN) (the "Company"), formerly BioDrain M...
Devices, Surgery, Radiology, Product Launch
Skyline Medical, STREAMWAY System, surgical fluid disposal

ZIO(R) Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine

周四, 01/02/2014 - 12:49
SAN FRANCISCO, Jan. 2, 2014 -- (Healthcare Sales & Marketing Network) -- iRhythm Technologies, a healthcare information services company, today announced that a prospective study by Scripps Translational Science Institute (STSI) has found that use of the ...
Devices, Cardiology, Monitoring
iRhythm Technologies, ZIO Service, ZIO Patch, arrhythmia, holter monitor

CytoSorbents Provides Clinical Update on CytoSorb Dosing Study

周二, 12/31/2013 - 15:47
MONMOUTH JUNCTION, NJ--(Healthcare Sales & Marketing Network) - CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company working to control inflammation and save lives in the ICU through blood purification with its European Union appro...
Devices
CytoSorbents, CytoSorb, cytokine filter, cytokine storm, septic shock

Miraculins and Cachet Pharmaceutical Agree to 30-Day Extension on Letter of Intent to Continue Negotiation of Licensing Rights for SCOUT DS(R) Diabetes Test in China

周二, 12/31/2013 - 15:42
Original 90-Day Negotiation Period Now Extended to January 30, 2014 WINNIPEG, MANITOBA--(Healthcare Sales & Marketing Network) - Miraculins Inc. (TSX VENTURE:MOM) ("Miraculins" or the "Company"), a medical diagnostic company focused ...
Diagnostics, Endocrinology, Licensing
Miraculins, Cachet Pharmaceutical, SCOUT DS, Diabetes Test, diabetes

Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases

周二, 12/31/2013 - 15:37
NEW YORK--(Healthcare Sales & Marketing Network)--Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on rare genetic diseases, announced today that the company has completed an $8 million dollar financing. Proceeds from the financing...
Biopharmaceuticals, Neurology, Venture Capital
Agilis Biotherapeutics, Friedreich’s Ataxia

George S. Zorich Named Chief Executive Officer of Agilis Biotherapeutics

周二, 12/31/2013 - 15:35
NEW YORK--(Healthcare Sales & Marketing Network)--Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today that George S. Zorich has been named Chief Executive Of...
Biopharmaceuticals, Personnel
Agilis Biotherapeutics

Star Scientific Receives a Warning Letter From the FDA Regarding Consumer Products

周二, 12/31/2013 - 15:32
GLEN ALLEN, Va., Dec. 31, 2013 -- (Healthcare Sales & Marketing Network) -- Star Scientific, Inc. (NASDAQ: STSI) announced the receipt on December 24, 2013, of a warning letter from the U.S. Food and Drug Administration (FDA) regarding two consumer produc...
Biopharmaceuticals, FDA
Star Scientific, Anatabloc, CigRx, anatabine

Patient Safety Technologies, Inc. Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $2.22 Per Common Share in Cash

周二, 12/31/2013 - 15:29
IRVINE, Calif., Dec. 31, 2013 -- (Healthcare Sales & Marketing Network) -- Patient Safety Technologies, Inc. (OTCBB:PSTX, OTCQB:PSTX) ("PST" or the "Company") today announced a definitive agreement with Stryker Corporation (NYSE: SYK) ...
Devices, Surgery, Mergers & Acquisitions
Stryker, Patient Safety Technologies, SurgiCount Medical, Safety-Sponge

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong